SCHEMBL22017295

SCHEMBL22017295

O=C(N[C@@H](CCO)c1ccc(F)cc1)[C@@H]1SCCN1S(=O)(=O)Cc1ccc(-c2ccccc2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGFR P43088 1/20 0.58
CCR5 P51681 1/20 0.38
LMNA P02545 1/20 0.37
POLB P06746 1/20 0.37
FKBP1A P62942 1/20 0.37
PRKACA P17612 1/20 0.35
CDK8 P49336 1/20 0.35
GSK3A P49840 1/20 0.35
GSK3B P49841 1/20 0.35
PRKX P51817 1/20 0.35
PRKCQ Q04759 1/20 0.35
ROCK1 Q13464 1/20 0.35
CLK4 Q9HAZ1 1/20 0.35
ALDH1A1 P00352 1/20 0.35
GLA P06280 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
MMP8 P22894 2/20 0.35
MMP12 P39900 2/20 0.35
MMP13 P45452 1/20 0.35
GPR183 P32249 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27049055 0.88 PTGFR (0.73) PTGFRMMP8HSD11B1MMP2MMP9
SCHEMBL3381107 0.88 PTGFR (0.73) PTGFRMMP8HSD11B1MMP2MMP9
SCHEMBL3382048 0.88 PTGFR (0.73) PTGFRMMP8HSD11B1MMP2MMP9
SCHEMBL22017043 0.85 PTGFR (0.81) PTGFRCCR5LMNAPOLBFKBP1A
SCHEMBL3382579 0.81 PTGFR (0.64) PTGFRPRKACACDK8GSK3AGSK3B
SCHEMBL3386103 0.81 PTGFR (0.64) PTGFRPRKACACDK8GSK3AGSK3B
SCHEMBL3382557 0.81 PTGFR (0.64) PTGFRPRKACACDK8GSK3AGSK3B
SCHEMBL3382653 0.81 PTGFR (0.64) PTGFRPRKACACDK8GSK3AGSK3B
SCHEMBL3383620 0.81 PTGFR (0.64) PTGFRPRKACACDK8GSK3AGSK3B
SCHEMBL3382831 0.80 PTGFR (0.64) PTGFRHSD11B1MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11524003-B2 Alpha-amino esters of hydroxypropylthiazolidine carboxamide derivative and salt form, crystal polymorph thereof ObsEva S.A. (CH) 2022-12-13 US disclosed
US-20200155515-A1 ALPHA-AMINO ESTERS OF HYDROXYPROPYLTHIAZOLIDINE CARBOXAMIDE DERIVATIVE AND SALT FORM, CRYSTAL POLYMORPH THEREOF XOMA (US) LLC 2020-05-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200155515-A1 ALPHA-AMINO ESTERS OF HYDROXYPROPYLTHIAZOLIDINE CARBOXAMIDE DERIVATIVE AND SALT FORM, CRYSTAL POLYMORPH THEREOF PGF, PTGER1, PTGER4 PTGFR 6/4885CCR5 1085/4885LMNA 1791/4885
US-11524003-B2 Alpha-amino esters of hydroxypropylthiazolidine carboxamide derivative and salt form, crystal polymorph thereof PGF, PTGER1, PTGER4 PTGFR 6/4885CCR5 1085/4885LMNA 1791/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.